XCHC Reports on 'American Drug War 2' National Theatrical Release on June 6, 2013; TheStockRadio.com Interview With Kevin Booth

May 02, 2013, 10:40 ET from X-Change Corporation

DALLAS, May 2, 2013  /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is cannabinoid extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, is proud to be part of the strategic team for 'American Drug War 2'.  TheStockRadio.com interviewed Mr. Booth about the film and its National Release on June 6, 2013.

The interview is available at http://thestockradio.com/director-kevin-booth-maker-of-american-drug-war-2/2629

A trailer for 'AMERICAN DRUG WAR 2' can be seen at http://www.youtube.com/user/AmericanDrugWar

Robert Kane, President of X-Change Corp., commented, "It is a privilege to be a part of some of the initial planning of the film and to have an appearance in the movie.  The Cash Hyde story, which is shared in the American Drug War 2 film, is one that is important and should be shared.  I encourage everyone interested in doing something positive in your community to go to www.tuggs.com and/or come out and support one of the events on June 6."

About 'American Drug War 2'

The film's distribution is being headed up by Gravitas Venture, a trend setting company that specializes in world-wide video-on-demand, as well as a theatrical release, through on-line start up TUGG.com. "Basically anyone - anywhere can go to TUGG.com and request a screening in his or her own area at a favorite theater. It's a new concept revolutionizing the industry called 'Theaters on Demand.' Once your theater has sold approximately 50 tickets – your event is booked. It's free and allows fans not only to participate but also to earn a little extra to give back to local legalization efforts. Simply go to http://www.tugg.com/titles/american-drug-war-2 and become one of our hosts," stated Kevin Booth, who hopes to blanket the country with the film on June 6, 2013.

About TheStockRadio.com

TheStockRadio.com is a small-cap research and investment commentary provider. TheStockRadio.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. It provide investors with an excellent first step in their research and due diligence by providing daily trading ideas and consolidating the public information available on these companies. For more information on TheStockRadio.com, please visit http://thestockradio.com.

TheStockRadio.com Disclosure

TheStockRadio.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. TheStockRadio.com is a website wholly owned by Allan James Group. Neither TheStockRadio.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please visit its website, TheStockRadio.com, for complete risks and disclosures.

Contact: mailto: info@thestockradio.com

About Cash Hyde Foundation


The Cash Hyde Foundation's Statement:

It is up to all of us to play a part in fighting cancer during our lifetime. Cashy's journey has given us all the opportunity to unite, with the same common goal, to help children fighting cancer.  The Cash Hyde Foundation's mission is to fight cancer with smiles, prayers, and positive energy and to provide information and financial support for children with cancer and their families.

How We Help:

  • Make custom Reggae Runners, and donate them to patients at Children's Hospitals. 
  • Help families in need to organize fundraisers so they can concentrate on fighting cancer.
  • Collect donations and organize fundraisers to financially assist the Foundation with its projects and financial support for children with cancer and their families.  
  • Create childhood cancer awareness in our communities and support for children with cancer and their families. 

About Phytiva Brand Product Lines

X-Change Corp. expects to develop and launch various innovative Phytiva Brand product lines.  The first is the Phytiva Brand European Line, which is an inventive line that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a cannabinoid based product line, utilizing the unique and potent benefits of cannabinoids.  Phytiva's revolutionary formulations target not just the symptom, but also the cause.  Cannabinoids and their sources constitute an ideal base for therapeutic solutions and have been utilized for centuries in skin and other remedies.

About The X-Change Corporation

X-Change Corp. is U.S. boutique Company whose niche is cannabinoid based extracts and products that target critical ailment, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva lines will be launched with cannabinoid based formulations through the launching of a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, and other legal state and foreign grow operations, on a jurisdiction by jurisdiction approved basis.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp.
President & CEO
Robert Kane

SOURCE X-Change Corporation